using wegovy pills for weight lossWegovy Tablets: UK’s First Oral GLP-1 Weight Loss Treatment

Wegovy tablets mark a genuine turning point in weight loss treatment in the UK. The UK government has confirmed approval of the first oral GLP-1 tablet for weight loss, a semaglutide tablet, marking a significant milestone in weight management treatment. For patients reluctant to start injectable treatment, this needle-free option offers a welcome alternative. Our Weight Loss Clinics are closely following the rollout and can advise on the most appropriate option from our full range of weight loss treatments.

Curious whether Wegovy tablets could be right for you? Book a consultation today.

Key Takeaways

  • Wegovy tablets contain semaglutide, the same active ingredient as the Wegovy injection, and have been approved for use in the UK.
  • The tablet is typically taken daily on an empty stomach, with a specific routine usually required for proper absorption.
  • Clinical trials show an average weight loss of approximately 16.6% over 64 weeks.
  • Early access is expected primarily through private clinics as the treatment becomes more widely available.
  • A clinical assessment is required before starting treatment.

use wegovy pills

What are Wegovy Tablets?

 

Wegovy tablets contain semaglutide, the same active ingredient found in the Wegovy injection. It belongs to a class of medications called GLP-1 receptor agonists, working by reducing appetite, increasing fullness, and slowing stomach emptying. Together, these effects help reduce calorie intake and support sustained weight loss. You can read more about semaglutide on the NHS website.

Tablet vs Injection: What is the Difference?

 

While both forms share the same active ingredient and mechanism, there are practical differences. The tablet is usually taken daily, and the injection once a week. Oral semaglutide has lower gut absorption, so the tablet typically requires a higher maximum dose of around 25mg daily, compared to 2.4mg weekly for the injection. Both have shown broadly similar outcomes, with average weight loss ranging from approximately 14 to 17% in trials.

Dosing and How to Take It

 

Treatment usually begins at a low dose and is generally increased gradually over time up to a higher maintenance level. Oral semaglutide is typically taken after a period of fasting, usually with only a small amount of water, with food or drink generally avoided for a short period afterwards to support absorption. Your prescribing clinician will provide the exact dosing schedule specific to your treatment, as this can vary between individuals.

Wegovy Tablet vs Injection at a Glance

FeatureDetail
FormDaily tablet vs weekly injection
Active IngredientSemaglutide in both forms
Typical Maximum Dose~25mg daily (tablet) vs 2.4mg weekly (injection)
AdministrationTablet typically requires fasting and specific timing; injection is usually more flexible
Average Weight Loss~16.6% (tablet) vs broadly similar with injection

Not sure whether tablets or injections are right for you?

Our clinical team will assess your suitability and explain your options as access expands. Contact Birmingham Weight Loss Clinics to find out more.

 

Who is Eligible for Wegovy Tablets?

 

Wegovy tablets are typically prescribed for adults with a BMI of 30 or above, or 27 or above with a weight-related condition such as diabetes or hypertension. A full clinical assessment is required before any prescription is issued. Early access is expected primarily through private clinics, with demand likely to outstrip supply initially. Patients curious about real results have found it helpful to look at Wegovy before and after results from our existing injectable programme.

Safety, Side Effects, and a Word of Caution

 

The side effect profile is similar to that of the injection, with the most common effects being nausea, vomiting, diarrhoea, and constipation. Less common but more serious risks include pancreatitis and gallbladder issues, and the medication is not suitable for everyone. Treatment is only used under medical supervision following a clinical assessment.

Given the high demand expected, we want to flag an important warning. Counterfeit and unlicensed weight loss medications are increasingly sold online, often at suspiciously low prices. Always obtain Wegovy tablets through a registered UK pharmacy with a genuine prescription. Our guide on buying Wegovy online in Birmingham explains how to do so safely.

lose weight on wegovy pills

Frequently Asked Questions

 

Are Wegovy tablets the same as Rybelsus?

Both contain semaglutide but are not the same product. Rybelsus is a lower-dose oral semaglutide approved for type 2 diabetes, while the Wegovy tablet is a higher-dose formulation approved for weight management and should not be used interchangeably.

Why does the tablet need to be taken on an empty stomach?

Oral semaglutide generally has low gut absorption, which is why it is typically taken following a period of fasting and usually with only a small amount of water. Your prescribing clinician will explain the specific routine that applies to your treatment, as following it correctly can affect how well the medication is absorbed.

Is the Wegovy tablet officially approved for use in the UK?

Yes. The UK government has confirmed that the oral semaglutide tablet has been approved for weight loss, making it the first GLP-1 tablet of its kind available in the UK. As with any newly approved medication, access is expected to expand gradually, with early availability primarily through private clinics.

A New Era of Weight Loss Treatment in Birmingham

Wegovy tablets represent an exciting, needle-free option for weight management, backed by clinical evidence and now approved in the UK. As access develops, Birmingham Weight Loss Clinics is committed to keeping patients informed and ensuring safe, clinically supervised treatment, whichever option suits them best.

Book your consultation today  |  Contact Us

⚕ Disclaimer: The information provided in this article is intended for general informational and educational purposes only and does not constitute medical advice. Wegovy tablets are a prescription-only medication and must only be used under the supervision of a qualified healthcare professional. Availability and eligibility criteria are subject to change as this is a newly approved treatment. Always consult a clinician before starting any new medication.
☑ Clinically Reviewed by Pharmacy Mentor
A pharmacist reviews the content to help ensure medicines are presented responsibly and that patient-facing health information is accurate, appropriate, and aligned with current clinical guidance.
Last reviewed: 23 June 2026
Written on behalf of Birmingham Weight Loss Clinics by Pharmacy Mentor.
wegovy weight loss pillThe Wegovy Pill: Everything You Need to Know About the New Weight Loss Tablet

The Wegovy pill is the latest development in weight loss treatment and one of the most significant breakthroughs in obesity medicine in years. It is an oral tablet containing semaglutide, the same active ingredient found in the Wegovy injection, and the first time a GLP-1 medication has been available in tablet form specifically for weight loss in the UK. For people who have been hesitant about injections, it opens up a genuinely new option. At Birmingham Weight Loss Clinics, our weight loss consultations are the best starting point for anyone curious about whether this treatment could be right for them.

Interested in the Wegovy pill? Book a consultation to discuss your options.

Key Takeaways

What is the Wegovy Pill?

The Wegovy pill is a once-daily oral tablet containing semaglutide, a GLP-1 receptor agonist that mimics a naturally occurring hormone involved in appetite regulation. According to the UK government, the Wegovy pill is the first GLP-1 tablet approved specifically for weight loss in the UK, having received regulatory approval in June 2026. It works by reducing appetite, increasing feelings of fullness, and slowing stomach emptying.

Semaglutide is not a new ingredient, as it is also found in Wegovy injections, Ozempic (for type 2 diabetes), and Rybelsus (oral semaglutide for diabetes). What makes the Wegovy pill distinct is that it is the first oral formulation approved specifically for weight management. You can read more about semaglutide on the NHS website.

pill wegovy

How Effective is the Wegovy Pill?

Clinical trials have shown average body weight loss of approximately 15 to 17% over around 64 weeks, placing the Wegovy pill among the most effective non-surgical weight loss treatments currently available. Results vary depending on dose, adherence, and lifestyle changes made alongside treatment. As with all GLP-1 treatments, it works best as part of a clinically supervised programme.

Wegovy Pill vs Wegovy Injection

FeatureDetail
FormOral tablet (pill) vs subcutaneous injection
FrequencyDaily (pill) vs weekly (injection)
AbsorptionMore variable with the pill; more consistent with the injection
Average Weight LossBroadly similar, approximately 15 to 17% in trials for both
Clinical EquivalenceSimilar but not clinically identical; assessment needed to determine the most appropriate option

Not sure whether the pill or injection is more suitable for you?

Our clinical team will assess your individual circumstances and help you understand all available options. Contact Birmingham Weight Loss Clinics to speak with us today.

Current UK Availability and Access

The Wegovy pill is currently available privately through clinics and pharmacies in the UK, with high demand and waiting lists already reported at some providers. It is not yet available on the NHS, which is awaiting its own separate evaluation. As with weight loss injections, counterfeit products being sold online are a genuine concern, and the pill should only be obtained through a registered UK clinic or pharmacy following a clinical assessment. Our blog on Mounjaro vs Wegovy is a useful reference for comparing injectable and tablet options.

Switching from Injection to the Wegovy Pill

For patients already on a weight-loss injection who are considering switching to the Wegovy pill, understanding the approximate dose equivalences can be helpful context. The tables below provide estimated equivalences between injection and tablet doses, based on currently available guidance. These are best estimates only and should not be used to self-adjust or change your treatment without speaking to your prescribing clinician first. Any switch between forms of medication should always be managed by a healthcare professional.

Note: The dose equivalences shown below are approximate estimates based on current clinical guidance and are provided for general information only. They do not constitute medical advice. Always consult your prescribing clinician before making any changes to your treatment.

Estimated Equivalent Strengths: Wegovy Injection to Wegovy Pill

Wegovy Injection DoseWegovy Pill Dose (Estimated)
0.25mg4mg
0.5mg4mg
1mg9mg
1.7mg9mg
2.4mg25mg
7.2mg25mg

Estimated Equivalent Strengths: Mounjaro Injection to Wegovy Pill

Mounjaro Injection DoseWegovy Pill Dose (Estimated)
2.5mg9mg
5mg9mg
7.5mg25mg
10mg25mg
12.5mg25mg
15mg25mg

 

The side effect profile is broadly similar to the injection, with the most commonly reported effects being nausea, vomiting, diarrhoea, and constipation. These are typical of GLP-1 medications and often improve over time. The pill is typically taken on an empty stomach with a specific fasting routine to support absorption, though your prescribing clinician will explain the exact approach for your treatment. It is not suitable for everyone and requires a clinical assessment before prescribing.

weight loss wegovy pill

Frequently Asked Questions

Is the Wegovy pill the same as Rybelsus?

Both contain semaglutide, but they are different products. Rybelsus is a lower-dose oral semaglutide approved for type 2 diabetes, while the Wegovy pill is a higher-dose formulation approved for weight loss. They should not be used interchangeably.

Who is eligible for the Wegovy pill in the UK?

The Wegovy pill is typically prescribed for adults with a BMI of 30 or above, or 27 or above with a weight-related health condition such as diabetes or hypertension. A clinical assessment is required to confirm suitability before any prescription is issued.

How does the Wegovy pill compare to Mounjaro?

Mounjaro (tirzepatide) acts on both GLP-1 and GIP receptors, while the Wegovy pill acts on GLP-1 only. Trial data suggests Mounjaro produces slightly greater average weight loss at the highest dose. The most appropriate choice depends on individual suitability determined at consultation.

Can I access the Wegovy pill at Birmingham Weight Loss Clinics?

We are actively following the rollout of this new treatment. Book a consultation and our clinical team will advise on your options based on current availability and your individual health profile.

A New Chapter in Weight Loss Treatment

The Wegovy pill is a significant development for anyone who has wanted GLP-1 therapy without injections. At Birmingham Weight Loss Clinics, our clinical team is here to help you navigate your options and support you with a programme built around your individual needs.

Book your consultation today  |  Contact Us

⚕ Disclaimer: The information provided in this article is intended for general informational and educational purposes only and does not constitute medical advice. The Wegovy pill is a prescription-only medication and must only be obtained through a qualified healthcare professional following a proper clinical assessment. Availability and eligibility criteria are subject to change. Always consult a clinician before starting any new medication.
☑ Clinically Reviewed by Pharmacy Mentor
A pharmacist reviews the content to help ensure medicines are presented responsibly and that patient-facing health information is accurate, appropriate, and aligned with current clinical guidance.
Last reviewed: 10 July 2026
Written on behalf of Birmingham Weight Loss Clinics by Pharmacy Mentor.